80
74
Growth Score 80 in past quarter
-5 pts
Heat Score 74 in past quarter
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
260759
Stratagen Bio is committed to developing high impact technologies to enable clinicians to make more informed treatment decisions.
- Gregory Ekchian: Co-Founder, CEO
Michael Cima: Director, FounderPast Role: Springleaf Therapeutics, Founder
About the Company
Stratagen Bio’s oxygen sensing technology was developed in labs at MIT’s Koch Institute for Integrative Cancer Research and the Department of Materials Science and Engineering. We are committed to developing high impact technologies to enable clinicians to make more informed treatment decisions and improve patient care.